Brian Lowes
机构: Cardiology, University of Nebraska Medical Center
每年引用次数
引用次数
引用: 10,441
H-指数: 47
I10-指数 : 99
出版物: 350
Improved ventilatory response at peak exercise despite no change in peak oxygen consumption with chronic beta-blockade in heart failure patients
Eugene E Wolfel , Tatiana O Tsvetkova , Brain D Lowes , JoAnn Lindenfeld
Journal of the American College of Cardiology 39 183
1
2002
Angiotensin II formation in the intact human heart. Predominance of the angiotensin-converting enzyme pathway.
L S Zisman , W T Abraham , G E Meixell , B N Vamvakias
Journal of Clinical Investigation 96 ( 3) 1490 -1498
113
1995
Changes in gene expression in the intact human heart. Downregulation of alpha-myosin heavy chain in hypertrophied, failing ventricular myocardium.
B D Lowes , W Minobe , W T Abraham , M N Rizeq
Journal of Clinical Investigation 100 ( 9) 2315 -2324
439
1997
Signaling Pathways Responsible for Fetal Gene Induction in the Failing Human Heart Evidence for Altered Thyroid Hormone Receptor Gene Expression
Koichiro Kinugawa , Wayne A. Minobe , William M. Wood , E. Chester Ridgway
Circulation 103 ( 8) 1089 -1094
109
2001
Serial gene expression profiling in the intact human heart.
B LOWES , R ZOLTY , W MINOBE , A ROBERTSON
Journal of Heart and Lung Transplantation 25 ( 5) 579 -588
30
2006
Peak oxygen consumption and outcome in heart failure patients chronically treated with β-blockers
S SHAKAR , B LOWES , J LINDENFELD , R ZOLTY
Journal of Cardiac Failure 10 ( 1) 15 -20
33
2004
CLINICAL RELEVANCE OF INVERSE AGONISM AND GUANINE-NUCLEOTIDE MODULATABLE BINDING-PROPERTIES OF BETA-ADRENERGIC-RECEPTOR BLOCKING-AGENTS
BD Lowes , P Chidiac , S Olsen , JD Port
Circulation 90 ( 4) 543 -543
23
1994
OPC-18790 PRODUCES TITRATABLE HEMODYNAMIC BENEFIT IN HOSPITALIZED-PATIENTS WITH SEVERE CONGESTIVE-HEART-FAILURE
RJ Cody , CV Leier , MR Bristow , MA Fifer
Circulation 88 ( 4) 300 -300
7
1993
Heart rate reduction or ventricular reverse remodeling associated with beta-blocker therapy is accompanied widespread, distinct changes in the beta1-adrenergic receptor gene signaling network
DP Kao , BD Lowes , EM Gilbert , W Minobe
EUROPEAN JOURNAL OF HEART FAILURE 18 483 -483
2016
Abraham, WT, 85, 265 Adams, KF, 201 Alves, L., 188 Anwar, F., 308
MA Arstall , DB Badesch , AJ Bank , CJ Barrett
Journal of Cardiac Failure 5 ( 4)
1999
Effects of an oral, nonpeptide, selective V-2 receptor vasopressin antagonist in patients with chronic heart failure
WT Abraham , RM Oren , TS Crisman , AD Robertson
Journal of the American College of Cardiology 29 ( 2) 7271 -7271
34
1997
Carvedilol is associated with a reversal of remodeling in chronic heart failure
BD Lowes , EA Gill , J RodriguezLarrain , WT Abraham
Circulation 94 ( 8) 2371 -2371
22
1996
Changes in myocardial gene expression associated with β-blocker-related improvement in ventricular systolic function
MR Bristow , EM Gilbert , BD Lowes , WA Minobe
Circulation 96 I -92
13
1997
Sympatholytic effect of bucindolol adversely affected survival, and was disproportionately observed in the class IV subgroup of BEST
MR Bristow , H Krause-Steinrauf , WT Abraham , L Chang-Seng
Circulation 104 ( 17) 755 -755
12
2001
Mechanism of increased cardiac adrenergic activity in heart failure: Evidence for decreased cardiac neuronal norepinephrine reuptake.
WT Abraham , BD Lowes , RL Roden , MR Gilbert
Circulation 96 ( 8) 503 -503
6
1997
Dynamic Changes in the expression of contractility-regulating genes in the failing human heart associated with improvement or deterioration in ventricular systolic function
BD Lowes , WT Abraham , WA Minobe , EM Gilbert
Circulation 98 ( 17) 361 -361
5
1998
Downregulation of alpha-and upregulation of beta-myosin heavy chain in intact, failing human ventricles
BD Lowes , WA Minobe , WT Abraham , RL Roden
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY 29 ( 2) 4029 -4029
5
1997
ANGIOTENSIN-II SELECTIVELY INCREASES CARDIAC ADRENERGIC ACTIVITY IN PATIENTS WITH HEART-FAILURE
WT Abraham , BD Lowes , CP Rose , P Larrabee
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY A215 -A215
5
1994
Changes in gene expression in the intact human heart
BD Lowes , W Minobe , WT Abraham
Downregulation of alpha-myosin• Treatment of RVF is directed toward the underlying etiology, complemented by general measures. RVF-directed therapies target alterations in preload, contractility/mechanics, and/or afterload 2315 -24
4
Carvedilol reduces QT dispersion in patients with congestive heart failure
EA Gill , EM Gilbert , BD Lowes , WT Abraham
CIRCULATION 96 ( 8) 3229 -3229
2
1997